(NEW YORK)A regulatory delay for Takeda Pharmaceuticals developing diabetes drug alogliptin helped boost shares of competitor Merck & Co. Monday, highlighting the competitive nature of diabe...READ MORE

(NEW YORK)Shares of Amylin Pharmaceuticals Inc. fell Thursday, as investors remained concerned about the company's third-quarter sales for the diabetes treatment Byetta and regulatory timeli...READ MORE

(NEW YORK)Biotechnology stocks managed to gain ground during a highly volatile third quarter as potential blockbuster drugs and multibillion-dollar buyout bids gave the largest players a ste...READ MORE

(NEW YORK)Big pharmaceutical companies and their biotech cousins will likely weather the financial crisis engulfing Wall Street, several analysts said, because of the necessity of their prod...READ MORE

(NEW YORK)Shares of biotechnology companies continued following the broader market's wide sways Monday after a week of heightened concern over the health and future of Wall Street and nation...READ MORE

(NEW YORK)Shares of biotechnology company Amylin Pharmaceuticals Inc. jumped Monday following billionaire investor Carl Icahn's move to increase his ownership stake to 7.3 percent.READ MORE

(NEW YORK)Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSEREAD MORE